Biogen Company Profile (NASDAQ:BIIB)

Analyst Ratings

Consensus Ratings for Biogen (NASDAQ:BIIB) (?)
Ratings Breakdown: 9 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.64)
Consensus Price Target: $327.05 (13.82% upside)

Analysts' Ratings History for Biogen (NASDAQ:BIIB)
Show:
DateFirmActionRatingPrice TargetActions
7/26/2016Jefferies GroupReiterated RatingBuy$319.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016Robert W. BairdReiterated RatingNeutral$268.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2016HC WainwrightReiterated RatingBuy$360.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2016BMO Capital MarketsReiterated RatingMarket Perform$287.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2016Leerink SwannReiterated RatingMarket Perform$319.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2016Credit Suisse Group AGReiterated RatingHold$312.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Piper Jaffray Cos.Set Price TargetHold$293.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/21/2016Morgan StanleyBoost Price TargetOverweight$383.00 -> $385.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2016Bank of America Corp.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Sanford C. BernsteinInitiated CoverageOutperform$282.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Royal Bank Of CanadaReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/7/2016Citigroup Inc.DowngradeBuy -> Neutral$345.00 -> $295.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/23/2016Goldman Sachs Group Inc.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2016Stifel NicolausReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016JPMorgan Chase & Co.Reiterated RatingOverweight$403.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Barclays PLCReiterated RatingBuy$420.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Standpoint ResearchInitiated CoverageBuy$360.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageOverweight$344.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Raymond James Financial Inc.Reiterated RatingBuy$104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2015Oppenheimer Holdings Inc.Reiterated RatingSector PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015ArgusLower Price TargetBuy$450.00 -> $360.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Nomura Holdings Inc.Reiterated RatingNeutral$401.00 -> $442.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2014S&P Equity ResearchReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/26/2014 forward)

Earnings

Earnings History for Biogen (NASDAQ:BIIB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/19/2016        
7/21/2016Q216$4.69$5.21$2.79 billion$2.89 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2016Q116$4.47$4.79$2.75 billion$2.73 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$4.08$4.50$2.70 billion$2.84 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$3.80$4.48$2.65 billion$2.39 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2015Q215$4.10$4.22$2.71 billion$2.59 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015Q115$3.91$3.82$2.66 billion$2.56 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$3.77$4.09$2.64 billion$2.60 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q3$3.22$3.80$2.48 billion$2.50 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214$2.81$3.49$2.14 billion$2.42 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q114$2.56$2.47$2.00 billion$2.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413$2.27$2.34$1.93 billion$2.00 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2013Q313$2.10$2.35$1.78 billion$1.83 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$1.93$2.30$1.62 billion$1.70 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$1.63$1.97$1.41 billion$1.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2013Q4 2012$1.46$1.40$1.38 billion$1.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$1.60$1.91ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$1.56$1.82ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$1.49$1.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$1.49$1.51ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2011$1.52$1.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2011$1.36$1.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2011$1.41$1.43ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2011$1.23$1.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Biogen (NASDAQ:BIIB)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$3.82$4.71$4.40
Q2 20164$4.41$4.74$4.62
Q3 20164$4.49$5.18$4.82
Q4 20164$4.81$5.17$5.03
Q1 20171$5.09$5.09$5.09
Q2 20171$5.16$5.16$5.16
Q3 20171$5.05$5.05$5.05
Q4 20172$4.94$5.01$4.98
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Biogen (NASDAQ:BIIB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biogen (NASDAQ:BIIB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/21/2016George A ScangosCEOSell157$280.00$43,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016Adam KoppelEVPSell555$290.00$160,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2016George A ScangosCEOSell842$290.00$244,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016George A ScangosCEOSell3,855$289.74$1,116,947.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016George A ScangosCEOSell157$280.00$43,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016George A ScangosCEOSell487$274.74$133,798.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Adam KoppelEVPSell102$275.00$28,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016George A ScangosCEOSell157$280.00$43,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016George A ScangosCEOSell487$258.83$126,050.21View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/1/2016George A ScangosCEOSell487$261.37$127,287.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Adriana KaraboutisEVPSell84$261.90$21,999.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Alfred SandrockCMOSell183$261.90$47,927.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Alfred SandrockChief Medical OfficerSell722$256.16$184,947.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016George A ScangosCEOSell487$256.16$124,749.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Alfred SandrockChief Medical OfficerSell852$246.54$210,052.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2015Alfred SandrockCMOSell441$277.00$122,157.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/23/2015Alexander J DennerDirectorBuy310,000$277.47$86,015,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/27/2015Stelios PapadopoulosDirectorBuy10,000$304.88$3,048,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2015Douglas E WilliamsEVPSell3,841$410.00$1,574,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015George A ScangosCEOSell1,362$398.87$543,260.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015George A ScangosCEOSell1,362$423.20$576,398.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015John CoxEVPSell12,010$449.06$5,393,210.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2015Eric K RowinskyDirectorSell11,667$475.00$5,541,825.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Eric K RowinskyDirectorSell2,333$436.14$1,017,514.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Eric K RowinskyDirectorSell4,667$425.45$1,985,575.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Robert W PangiaDirectorSell3,625$413.40$1,498,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Alfred SandrockSVPSell3,174$409.49$1,299,721.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Steven H HoltzmanEVPSell2,128$389.11$828,026.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2015Alfred SandrockSVPSell1,143$398.11$455,039.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Kenneth DipietroEVPSell1,656$389.03$644,233.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Spyridon Artavanis-TsakonasSVPSell1,981$346.50$686,416.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014Steven H HoltzmanEVPSell1,749$335.65$587,051.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2014Steven H HoltzmanEVPSell1,750$330.00$577,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014George A ScangosCEOSell1,128$320.78$361,839.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014George A ScangosCEOSell1,127$330.97$373,003.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Steven H HoltzmanEVPSell1,750$330.97$579,197.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014George A ScangosCEOSell1,128$332.93$375,545.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014George A ScangosCEOSell12,316$312.37$3,847,148.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Steven HoltzmanEVPSell1,221$289.15$353,052.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014George ScangosCEOSell2,123$285.56$606,243.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2014Steven HoltzmanEVPSell1,221$291.00$355,311.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014George ScangosCEOSell2,123$308.42$654,775.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Robert PangiaDirectorSell6,250$308.42$1,927,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2014Brian PosnerDirectorSell3,000$296.76$890,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Caroline DorsaDirectorSell10,000$348.88$3,488,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2014Douglas WilliamsEVPSell3,505$352.29$1,234,776.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Steven HoltzmanEVPSell1,221$334.83$408,827.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Stuart KingsleyEVPSell8,428$336.83$2,838,803.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014George ScangosCEOSell2,942$335.79$987,894.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2014Alfred SandrockSVPSell1,048$342.17$358,594.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Steven HoltzmanEVPSell1,222$327.90$400,693.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Kenneth DipietroEVPSell1,290$316.81$408,684.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Alfred SandrockSVPSell2,085$314.31$655,336.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014George ScangosCEOSell2,456$314.31$771,945.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Kenneth DipietroEVPSell1,655$299.01$494,861.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2014Eric RowinskyDirectorSell2,020$310.09$626,381.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Lynn SchenkDirectorSell1,000$297.48$297,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2014William YoungDirectorSell15,000$285.11$4,276,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2014Robert PangiaDirectorSell6,250$278.03$1,737,687.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2013Lynn SchenkDirectorSell1,000$291.71$291,710.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/22/2013Raymond PawlickiSVPSell4,000$288.00$1,152,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013George A ScangosCEOSell2,239$245.57$549,831.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2013Lynn SchenkDirectorSell1,000$245.00$245,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2013Alfred SandrockSVPSell15,030$250.11$3,759,153.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Paul ClancyCFOSell26,785$245.00$6,562,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2013Steven HoltzmanEVPSell3,501$238.98$836,668.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Paul ClancyCFOSell99,030$238.27$23,595,878.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Raymond PawlickiSVPSell4,000$238.03$952,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013George ScangosCEOSell2,239$214.40$480,041.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Douglas WilliamsEVPSell4,368$211.35$923,176.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013George A ScangosCEOSell2,239$218.82$489,937.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2013George A ScangosCEOSell2,239$223.94$501,401.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Alexander J DennerDirectorSell2,900$212.00$614,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2013Brian S PosnerDirectorSell2,020$219.62$443,632.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Lynn SchenkDirectorSell2,000$225.82$451,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013George A ScangosCEOSell1,598$234.16$374,187.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Stephen A SherwinDirectorSell12,825$233.26$2,991,559.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Robert W PangiaDirectorSell5,900$237.23$1,399,657.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/27/2012Alexander J DennerDirectorSell7,980$148.62$1,185,987.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Biogen (NASDAQ:BIIB)
DateHeadline
07/25/16 07:36 AMWall Street Updates Ratings after Biogen’s (BIIB) Stellar Week
07/24/16 07:33 AMBiogen Q2 Plusses And Minuses - Seeking Alpha
07/23/16 02:47 PMFriday Session Wrap-up for Biogen Inc. (NASDAQ:BIIB) - Engelwood Daily
07/23/16 07:03 AMBiogen Inc. (BIIB) is Trading Higher on Unusual Volume for July 21 - Equities.com
07/22/16 02:48 PMStock Update: Biogen Idec Inc (NASDAQ:BIIB) - Post Earnings Coverage as Biogen Post 23% growth in EPS - Jutia Group (press release) (blog)
07/22/16 01:57 PMETF’s with exposure to Biogen, Inc. : July 22, 2016 -
07/22/16 11:24 AMBiogen (BIIB) Stock Up on CEO Transition, Fueling Sale Speculation -
07/22/16 11:13 AMSix Major Biotech Acquisitions You Could See in 2016 (Part 2) -
07/22/16 10:59 AMBiogen Inc (NASDAQ:BIIB) & BB&T Corporation (NYSE:BBT) Trader's Watch List - Money News (press release)
07/22/16 10:59 AMBiogen Inc. (BIIB) Pops 7.64% for July 21 - Equities.com
07/22/16 10:40 AMBiogen Should Either a Buyer or a Seller Be -
07/22/16 10:40 AMBiogen: Prelude to a Sale? -
07/22/16 10:33 AMBiogen Inc: How Double-Digit Growth Got Trumped -
07/22/16 09:00 AMBiogen Trounces Q2 Estimates; CEO to Retire Soon -
07/22/16 08:15 AMPost Earnings Coverage as Biogen Post 23% growth in EPS - [Accesswire] - LONDON, UK / ACCESSWIRE / July 22, 2016 / Active Wall St. announces its post-earnings coverage on Biogen Inc. (NASDAQ: BIIB ). The company announced its Q2 FY16 financial results before the opening bell ...
07/22/16 07:57 AMPost Earnings Coverage as Biogen Post 23 Percent growth in EPS -
07/21/16 08:22 PMBiogen Inc. Chief Steps Down (BIIB)
07/21/16 07:57 PM[$$] No Miracle Cures for Biogen - [at The Wall Street Journal] - Biogen’s strong results will support the stock price, but the new drug pipeline is thin.
07/21/16 02:50 PMAnalyst's Valuable Buzzers: Humana Inc. (NYSE:HUM) , Biogen Inc. (NASDAQ:BIIB) - Street Updates
07/21/16 02:50 PMBiotech Stocks To Put On Your Watch List: Biogen Inc. (NASDAQ:BIIB), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) - The Voice Registrar
07/21/16 02:33 PMBiogen CEO has 'mixed emotions' as he leaves company after 6 years -
07/21/16 02:26 PM[$$] Biogen Announces CEO Search, Lifts Guidance -
07/21/16 02:20 PM​Biogen CEO George Scangos to step down, search for successor to begin -
07/21/16 11:20 AMBiogen's stock jumps after results beat expectations; CEO to leave
07/21/16 11:20 AMBiogen beats Street forecasts
07/21/16 11:20 AMBuzz Stocks: Southwest Airlines Co, Biogen Inc, and Relypsa Inc
07/21/16 11:20 AMBiogen Inc (NASDAQ:BIIB) Jumps 5% On Solid Earnings And Guidance
07/21/16 11:20 AMBiogen Inc. (BIIB) Is Up Sharply On Strong Q2 Earnings
07/21/16 11:09 AMStocks Extend Declines as Southwest Pressures Airlines -
07/21/16 10:30 AMBiogen CEO Quits Amid M&A Speculation; Company Hikes Outlook -
07/21/16 10:22 AMBiogen rises after 2nd-quarter results surpass forecasts -
07/20/16 03:20 PMAnalyst Ratings Buzz: Biogen Inc. (NASDAQ:BIIB) - News Oracle
07/20/16 03:20 PMCim Lowers stake in Biogen Inc (BIIB) - TheFounders Daily
07/20/16 02:36 PMBiotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug -
07/20/16 01:51 PMBiogen: This is Getting Annoying -
07/20/16 09:27 AMBIIB Stock: What to Know About Biogen Inc Before Thursday Morning - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Biogen (BIIB) hit a wall a year ago when its flagship drug's sales growth stalled. This is not the same company though. The post BIIB Stock: What to Know About Biogen Inc Before Thursday Morning appeared first on InvestorPlace.
07/19/16 02:51 PMHot Watch List: Biogen Inc. (NASDAQ:BIIB), ConAgra Foods (NYSE:CAG) - Seneca Globe
07/19/16 02:51 PMCurrent Biogen Inc. (NASDAQ:BIIB) PT Means Stock Is Worth Almost $401 - Review Fortune
07/19/16 09:01 AMBiotech Stocks To Put On Your Watch List: Biogen Inc. (NASDAQ:BIIB), Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - The Voice Registrar
07/19/16 09:01 AMBiogen Inc (NASDAQ:BIIB) & NextEra Energy Inc (NYSE:NEE) Stocks Alert - Money News (press release)
07/18/16 02:54 PMBiotech news that matter for investors: Exelixis (NASDAQ:EXEL), Biogen (NASDAQ:BIIB) - The Voice Registrar
07/18/16 02:54 PMHealthcare Stocks on Trader's Radar: Biogen Inc (NASDAQ:BIIB), Incyte Corporation (NASDAQ:INCY) - Post Registrar
07/18/16 02:54 PMHC Stocks Momentum: EXACT Sciences Corporation (NASDAQ:EXAS) Biogen Inc (NASDAQ:BIIB) - share market updates (press release)
07/18/16 02:54 PMSamsung Bioepis and Biogen Inc (NASDAQ:BIIB) Closing In On Regulatory Approval for Humira Biosimilar SB5 - Market Exclusive
07/18/16 02:54 PMStock Performance to Track: Biogen Inc. (NASDAQ:BIIB) - News Oracle
07/18/16 02:05 PMBiogen’s Hemophilia Drugs Could See Strong Revenue Growth -
07/18/16 07:48 AMBiogen : SB5, An Adalimumab Biosimilar Referencing Humira®, Accepted for Review by European Medicines Agency
07/18/16 07:48 AMBiogen Inc. (BIIB) Jumped To Over A 1-Month High
07/18/16 07:48 AMSamsung Bioepis and Biogen Inc (NASDAQ:BIIB) Closing In On Regulatory Approval for Humira Biosimilar SB5
07/18/16 07:14 AMBiogen, Inc. breached its 50 day moving average in a Bullish Manner : BIIB-US : July 18, 2016 -

Social

About Biogen

Biogen logoBiogen Inc., formerly Biogen Idec Inc., is a biopharmaceutical company. The Company operates in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders segment. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B, and FUMADERM for the treatment of severe plaque psoriasis. It also has a collaboration agreement with Genentech, Inc., a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies. It also develops late stage product candidates, including Aducanumab (BIIB037) for the treatment of Neurodegeneration, and Nusinersen for other programs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: BIIB
  • CUSIP: 09062X10
Key Metrics:
  • Previous Close: $287.35
  • 50 Day Moving Average: $250.00
  • 200 Day Moving Average: $262.45
  • P/E Ratio: 16.79
  • P/E Growth: 1.61
  • Market Cap: $62.96B
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $20.2 EPS
  • Next Year EPS Consensus Estimate: $20.45 EPS
Additional Links:
Biogen (NASDAQ:BIIB) Chart for Tuesday, July, 26, 2016